Skip to content

Time Course of Endometrium's Gene Expression Profiles Using Endometrial Tissue and Blood Samples

Time Course of Endometrium's Gene Expression and DNA Methylation Profiles Using Endometrial Tissue and Blood Samples

Status
Completed
Phases
Early Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06786273
Enrollment
62
Registered
2025-01-22
Start date
2023-03-31
Completion date
2024-02-06
Last updated
2025-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fertility

Keywords

miRNAs, microRNAs, time course, blood

Brief summary

This study aims to investigate whether the expression levels of microRNA (miRNA) in endometrial tissue and blood samples at various time points after ovulation can serve as biomarkers for assessing endometrial receptivity.

Interventions

The blood and endometrial tissue samples collected from the study groups will undergo small RNA sequencing to investigate the microRNA expression profiles associated with that phase.

Sponsors

Inti Labs
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
SEQUENTIAL
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
25 Years to 38 Years
Healthy volunteers
Yes

Inclusion criteria

* Regular menstrual cycle of 28-32 days. * Between 25-38 years old. * BMI between 18 to 30. * Endogenous progesterone (P4) level of \< 1 ng/mL prior to exogenous progesterone administration

Exclusion criteria

* Suspected intrauterine abnormality. * Women who are breastfeeding * Have a history of pelvic inflammatory disease, reproductive tract-related diseases, sexually transmitted diseases, systemic diseases or endocrine diseases. * History of major illness. * Use of hormonal contraceptives or intrauterine devices in the past 3 months.

Design outcomes

Primary

MeasureTime frameDescription
miRNA expression profiles1 monthThe samples collected would undergo small RNA sequencing in order to investigate the miRNA expression profiles of the patients and differences in expression profiles between the different intervention groups.

Countries

Taiwan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026